Assessment of gut microbiota populations in lean and obese Zucker rats.
Obesity has been on the rise in the US and worldwide for the last several decades. Obesity has been associated with chronic disease development, such as certain types of cancer, type 2 diabetes, cardiovascular disease, and liver diseases. Previously, we reported that obesity promotes DMBA-induced ma...
Main Authors: | Reza Hakkak, Soheila Korourian, Steven L Foley, Bruce D Erickson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5509373?pdf=render |
Similar Items
-
Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
by: Reza Hakkak, et al.
Published: (2022-06-01) -
Metabolic Status of Lean and Obese Zucker Rats Based on Untargeted and Targeted Metabolomics Analysis of Serum
by: Stepan Melnyk, et al.
Published: (2022-01-01) -
Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease
by: Stepan Melnyk, et al.
Published: (2023-08-01) -
Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model
by: Reza Hakkak, et al.
Published: (2017-03-01) -
Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model
by: Michael S. Robeson, et al.
Published: (2022-03-01)